硫利达嗪及其代谢产物与精神病患者血清蛋白的结合情况。 - Suppr

Suppr

超能文献

Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients.

作者信息

Nyberg G, Axelsson R, Mårtensson E

出版信息

Eur J Clin Pharmacol. 1978 Dec 18;14(5):341-50. doi: 10.1007/BF00611904.

DOI:10.1007/BF00611904

PMID:32045

Abstract

摘要

相似文献

Binding of thioridazine and thioridazine metabolites to serum proteins in psychiatric patients.硫利达嗪及其代谢产物与精神病患者血清蛋白的结合情况。

Eur J Clin Pharmacol. 1978 Dec 18;14(5):341-50. doi: 10.1007/BF00611904.

Binding of thioridazine and some of its metabolites to human serum protein and human albumin.硫利达嗪及其某些代谢产物与人血清蛋白和人白蛋白的结合。

Arzneimittelforschung. 1975;25(12):1969-71.

Serum concentration and elimination from serum of thioridazine in psychiatric patients.硫利达嗪在精神病患者中的血清浓度及从血清中的消除情况。

Curr Ther Res Clin Exp. 1976 Feb;19(2):242-65.

Serum concentration and protein binding of thioridazine and its metabolites in patients with chronic alcoholism.慢性酒精中毒患者中硫利达嗪及其代谢物的血清浓度和蛋白结合情况。

Eur J Clin Pharmacol. 1982 Oct;23(4):359-63. doi: 10.1007/BF00613621.

Binding of thioridazine and thioridazine metabolites to serum proteins. An in vitro study.硫利达嗪及其代谢产物与血清蛋白的结合：一项体外研究。

Naunyn Schmiedebergs Arch Pharmacol. 1982 Jun;319(3):189-96. doi: 10.1007/BF00495864.

Cerebrospinal fluid concentrations of thioridazine and its main metabolites in psychiatric patients.精神病患者脑脊液中硫利达嗪及其主要代谢物的浓度。

Eur J Clin Pharmacol. 1981 Jan;19(2):139-48. doi: 10.1007/BF00568401.

Plasma and red cell levels of thioridazine and clinical response in schizophrenia.硫利达嗪的血浆和红细胞水平与精神分裂症的临床反应

Psychiatry Res. 1984 Aug;12(4):287-96. doi: 10.1016/0165-1781(84)90045-3.

Albumin binding of thioridazine and some of its metabolites.硫利达嗪及其某些代谢物的白蛋白结合情况。

Arch Int Pharmacodyn Ther. 1975 Mar;214(1):86-91.

Studies on thioridazine and mesoridazine metabolism. I. Protein binding.硫利达嗪和甲砜达嗪代谢的研究。I. 蛋白质结合。

Commun Psychopharmacol. 1979;3(5):319-22.

A fixed dose study of the plasma concentration and clinical effects of thioridazine and its major metabolites.硫利达嗪及其主要代谢产物的血药浓度和临床效果的固定剂量研究。

Psychopharmacology (Berl). 1989;97(4):481-8. doi: 10.1007/BF00439552.

引用本文的文献

Thioridazine pharmacokinetic-pharmacodynamic parameters "Wobble" during treatment of tuberculosis: a theoretical basis for shorter-duration curative monotherapy with congeners.硫利达嗪的药代动力学-药效学参数在结核病治疗期间“摆动”：同类药物短疗程治愈性单药治疗的理论基础。

Antimicrob Agents Chemother. 2013 Dec;57(12):5870-7. doi: 10.1128/AAC.00829-13. Epub 2013 Sep 16.

Effects of antipsychotic drugs on I(to), I (Na), I (sus), I (K1), and hERG: QT prolongation, structure activity relationship, and network analysis.抗精神病药物对I(to)、I(Na)、I(sus)、I(K1)和hERG的影响：QT间期延长、构效关系及网络分析

Pharm Res. 2006 Jun;23(6):1133-43. doi: 10.1007/s11095-006-0070-7. Epub 2006 May 25.

Evaluation of the rabbit Purkinje fibre assay as an in vitro tool for assessing the risk of drug-induced torsades de pointes in humans.评估兔浦肯野纤维试验作为评估人类药物诱发尖端扭转型室性心动过速风险的体外工具。

Drug Saf. 2006;29(3):237-54. doi: 10.2165/00002018-200629030-00007.

The effect of age and thioridazine on the in vitro binding of fluphenazine to normal human serum.年龄和硫利达嗪对氟奋乃静与正常人血清体外结合的影响。

Br J Clin Pharmacol. 1980 Apr;9(4):432-4. doi: 10.1111/j.1365-2125.1980.tb01074.x.

Total and free serum haloperidol levels in schizophrenic patients and the effect of age thioridazine and fatty acid on haloperidol-serum protein binding in vitro.精神分裂症患者血清中氟哌啶醇的总含量和游离含量以及年龄、硫利达嗪和脂肪酸对氟哌啶醇与血清蛋白体外结合的影响。

Br J Clin Pharmacol. 1981 Apr;11(4):377-82. doi: 10.1111/j.1365-2125.1981.tb01135.x.

Cerebrospinal fluid concentrations of thioridazine and its main metabolites in psychiatric patients.精神病患者脑脊液中硫利达嗪及其主要代谢物的浓度。

Eur J Clin Pharmacol. 1981 Jan;19(2):139-48. doi: 10.1007/BF00568401.

Eur J Clin Pharmacol. 1982 Oct;23(4):359-63. doi: 10.1007/BF00613621.

Binding of thioridazine and thioridazine metabolites to serum proteins. An in vitro study.硫利达嗪及其代谢产物与血清蛋白的结合：一项体外研究。

Naunyn Schmiedebergs Arch Pharmacol. 1982 Jun;319(3):189-96. doi: 10.1007/BF00495864.

A unitary mechanism of calcium antagonist drug action.钙拮抗剂药物作用的单一机制。

Proc Natl Acad Sci U S A. 1983 Feb;80(3):860-4. doi: 10.1073/pnas.80.3.860.

Plasma protein binding of perazine and amitriptyline in psychiatric patients.精神病患者中奋乃静和阿米替林的血浆蛋白结合情况。

Eur J Clin Pharmacol. 1982;22(4):367-73. doi: 10.1007/BF00548407.

本文引用的文献

Serum levels of thioridazine in psychiatric patients and healthy volunteers.精神病患者和健康志愿者的硫利达嗪血清水平。

Eur J Clin Pharmacol. 1973 Oct;6(3):181-6. doi: 10.1007/BF00558283.

Binding of thioridazine and some of its metabolites to human serum protein and human albumin.硫利达嗪及其某些代谢产物与人血清蛋白和人白蛋白的结合。

Arzneimittelforschung. 1975;25(12):1969-71.

Serum concentration and elimination from serum of thioridazine in psychiatric patients.硫利达嗪在精神病患者中的血清浓度及从血清中的消除情况。

Curr Ther Res Clin Exp. 1976 Feb;19(2):242-65.

Quantitative determination of thioridazine and nonconjugated thioridazine metabolites in serum and urine of psychiatric patients.精神病患者血清和尿液中硫利达嗪及非共轭硫利达嗪代谢物的定量测定。

Curr Ther Res Clin Exp. 1975 Nov;18(5):687-700.

Studies on serum protein binding of haloperidol.氟哌啶醇的血清蛋白结合研究。

Curr Ther Res Clin Exp. 1977 Feb;21(2):245-55.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验